Methylation profiling

Dataset Information

0

Epigenetic dosage identifies two major and functionally distinct β cell subtypes [DNAmethArray]


ABSTRACT: The mechanisms that specify and stabilize cell subtypes remain poorly understood. Here, we identify two major subtypes of pancreatic β cells based on histone mark heterogeneity (βHI and βLO). βHI cells exhibit ∼4-fold higher levels of H3K27me3, distinct chromatin organization and compaction, and a specific transcriptional pattern. βHI and βLO cells also differ in size, morphology, cytosolic and nuclear ultrastructure, epigenomes, cell surface marker expression, and function, and can be FACS separated into CD24+ and CD24− fractions. Functionally, βHI cells have increased mitochondrial mass, activity, and insulin secretion in vivo and ex vivo. Partial loss of function indicates that H3K27me3 dosage regulates βHI/βLO ratio in vivo, suggesting that control of β cell subtype identity and ratio is at least partially uncoupled. Both subtypes are conserved in humans, with βHI cells enriched in humans with type 2 diabetes. Thus, epigenetic dosage is a novel regulator of cell subtype specification and identifies two functionally distinct β cell subtypes.

ORGANISM(S): Mus musculus

PROVIDER: GSE224058 | GEO | 2023/02/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-02-16 | GSE224060 | GEO
2023-02-16 | GSE225436 | GEO
2023-02-16 | GSE224059 | GEO
| PRJNA929496 | ENA
| PRJNA929497 | ENA
| PRJNA929498 | ENA
| PRJNA935693 | ENA
| PRJNA929499 | ENA
2010-08-28 | E-GEOD-23844 | biostudies-arrayexpress
| 108044 | ecrin-mdr-crc